Glycogen synthase kinase-3β-mediated CCAAT/enhancer-binding protein delta phosphorylation in astrocytes promotes migration and activation of microglia/macrophages

Chiung Yuan Ko, Wen Ling Wang, Shao Ming Wang, Yu Yi Chu, Wen Chang Chang, Ju Ming Wang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Alzheimer's disease is neuropathologically characterized by the accumulation of amyloid-β protein into senile plaques that are sites of chronic inflammation involving reactive microglia, astrocytes, and proinflammatory molecules, such as interleukin-1β and tumor necrosis factor-α. The human CCAAT/enhancer-binding protein (CEBP) delta (CEBPD) is known to be induced in many inflammation-related diseases. In Alzheimer's disease, this protein is responsive to amyloid-β and proinflammatory cytokines in astrocytes. However, the functional role of CEBPD in astrocytes remains largely unclear. In this study, we show that CEBPD is upregulated by interleukin-1β through the mitogen-activated protein kinase p38 (MAPKp38) signaling pathway and phosphorylated by glycogen synthase kinase (GSK)-3β at Ser167 in astrocytes. CEBPD in astrocytes is associated with microglia activation and migration in amyloid precursor protein transgenic mice (AppTg) mice. We further identified that the monocyte chemotactic protein-1, a chemoattractive factor, and migration factors matrix metalloproteinase-1 and -3 are responsive to GSK3β-mediated CEBPD Ser167 phosphorylation. Our results revealed the novel regulation of LiCl on astrocytes and that GSK3β-mediated CEBPD phosphorylation in astrocytes plays an important role in the activation of microglia.

Original languageEnglish
Pages (from-to)24-34
Number of pages11
JournalNeurobiology of Aging
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

CCAAT-Enhancer-Binding Protein-delta
Glycogen Synthase Kinase 3
Macrophage Activation
Microglia
Astrocytes
Phosphorylation
Interleukin-1
Alzheimer Disease
Inflammation
Amyloidogenic Proteins
Matrix Metalloproteinase 3
Matrix Metalloproteinase 1
Amyloid beta-Protein Precursor
Chemokine CCL2
Amyloid Plaques
p38 Mitogen-Activated Protein Kinases
Amyloid
Transgenic Mice
Tumor Necrosis Factor-alpha
Cytokines

Keywords

  • Alzheimer's disease
  • Astrocytes
  • CEBPD
  • GSK3β
  • Microglia

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Ageing
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Glycogen synthase kinase-3β-mediated CCAAT/enhancer-binding protein delta phosphorylation in astrocytes promotes migration and activation of microglia/macrophages. / Ko, Chiung Yuan; Wang, Wen Ling; Wang, Shao Ming; Chu, Yu Yi; Chang, Wen Chang; Wang, Ju Ming.

In: Neurobiology of Aging, Vol. 35, No. 1, 01.2014, p. 24-34.

Research output: Contribution to journalArticle

@article{a3f9eee2cfc64c83a30dc2704e8c8f8e,
title = "Glycogen synthase kinase-3β-mediated CCAAT/enhancer-binding protein delta phosphorylation in astrocytes promotes migration and activation of microglia/macrophages",
abstract = "Alzheimer's disease is neuropathologically characterized by the accumulation of amyloid-β protein into senile plaques that are sites of chronic inflammation involving reactive microglia, astrocytes, and proinflammatory molecules, such as interleukin-1β and tumor necrosis factor-α. The human CCAAT/enhancer-binding protein (CEBP) delta (CEBPD) is known to be induced in many inflammation-related diseases. In Alzheimer's disease, this protein is responsive to amyloid-β and proinflammatory cytokines in astrocytes. However, the functional role of CEBPD in astrocytes remains largely unclear. In this study, we show that CEBPD is upregulated by interleukin-1β through the mitogen-activated protein kinase p38 (MAPKp38) signaling pathway and phosphorylated by glycogen synthase kinase (GSK)-3β at Ser167 in astrocytes. CEBPD in astrocytes is associated with microglia activation and migration in amyloid precursor protein transgenic mice (AppTg) mice. We further identified that the monocyte chemotactic protein-1, a chemoattractive factor, and migration factors matrix metalloproteinase-1 and -3 are responsive to GSK3β-mediated CEBPD Ser167 phosphorylation. Our results revealed the novel regulation of LiCl on astrocytes and that GSK3β-mediated CEBPD phosphorylation in astrocytes plays an important role in the activation of microglia.",
keywords = "Alzheimer's disease, Astrocytes, CEBPD, GSK3β, Microglia",
author = "Ko, {Chiung Yuan} and Wang, {Wen Ling} and Wang, {Shao Ming} and Chu, {Yu Yi} and Chang, {Wen Chang} and Wang, {Ju Ming}",
year = "2014",
month = "1",
doi = "10.1016/j.neurobiolaging.2013.07.021",
language = "English",
volume = "35",
pages = "24--34",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Glycogen synthase kinase-3β-mediated CCAAT/enhancer-binding protein delta phosphorylation in astrocytes promotes migration and activation of microglia/macrophages

AU - Ko, Chiung Yuan

AU - Wang, Wen Ling

AU - Wang, Shao Ming

AU - Chu, Yu Yi

AU - Chang, Wen Chang

AU - Wang, Ju Ming

PY - 2014/1

Y1 - 2014/1

N2 - Alzheimer's disease is neuropathologically characterized by the accumulation of amyloid-β protein into senile plaques that are sites of chronic inflammation involving reactive microglia, astrocytes, and proinflammatory molecules, such as interleukin-1β and tumor necrosis factor-α. The human CCAAT/enhancer-binding protein (CEBP) delta (CEBPD) is known to be induced in many inflammation-related diseases. In Alzheimer's disease, this protein is responsive to amyloid-β and proinflammatory cytokines in astrocytes. However, the functional role of CEBPD in astrocytes remains largely unclear. In this study, we show that CEBPD is upregulated by interleukin-1β through the mitogen-activated protein kinase p38 (MAPKp38) signaling pathway and phosphorylated by glycogen synthase kinase (GSK)-3β at Ser167 in astrocytes. CEBPD in astrocytes is associated with microglia activation and migration in amyloid precursor protein transgenic mice (AppTg) mice. We further identified that the monocyte chemotactic protein-1, a chemoattractive factor, and migration factors matrix metalloproteinase-1 and -3 are responsive to GSK3β-mediated CEBPD Ser167 phosphorylation. Our results revealed the novel regulation of LiCl on astrocytes and that GSK3β-mediated CEBPD phosphorylation in astrocytes plays an important role in the activation of microglia.

AB - Alzheimer's disease is neuropathologically characterized by the accumulation of amyloid-β protein into senile plaques that are sites of chronic inflammation involving reactive microglia, astrocytes, and proinflammatory molecules, such as interleukin-1β and tumor necrosis factor-α. The human CCAAT/enhancer-binding protein (CEBP) delta (CEBPD) is known to be induced in many inflammation-related diseases. In Alzheimer's disease, this protein is responsive to amyloid-β and proinflammatory cytokines in astrocytes. However, the functional role of CEBPD in astrocytes remains largely unclear. In this study, we show that CEBPD is upregulated by interleukin-1β through the mitogen-activated protein kinase p38 (MAPKp38) signaling pathway and phosphorylated by glycogen synthase kinase (GSK)-3β at Ser167 in astrocytes. CEBPD in astrocytes is associated with microglia activation and migration in amyloid precursor protein transgenic mice (AppTg) mice. We further identified that the monocyte chemotactic protein-1, a chemoattractive factor, and migration factors matrix metalloproteinase-1 and -3 are responsive to GSK3β-mediated CEBPD Ser167 phosphorylation. Our results revealed the novel regulation of LiCl on astrocytes and that GSK3β-mediated CEBPD phosphorylation in astrocytes plays an important role in the activation of microglia.

KW - Alzheimer's disease

KW - Astrocytes

KW - CEBPD

KW - GSK3β

KW - Microglia

UR - http://www.scopus.com/inward/record.url?scp=84885173010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885173010&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.07.021

DO - 10.1016/j.neurobiolaging.2013.07.021

M3 - Article

VL - 35

SP - 24

EP - 34

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 1

ER -